Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05484375 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
to evaluate the efficacy and safety of toripalimab and capecitabine maintenance therapy in patients with metastatic nasopharyngeal carcinoma (NPC) after first-line gemcitabine/cisplatin combined with toripalimab.
Trial Details
NCT Number NCT05484375
Lead Sponsor Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Collaborators: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Hunan Cancer Hospital
Conditions
(from sponsor)		 Metastatic Nasopharyngeal Carcinoma
Related terms Nasopharyngeal Carcinoma
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov